Targeting Microbiota 2020 will be a Virtual and in-Person Congress

We have been closely following updates and evolving guidance from local, national and global agencies for COVID-19. There is still much uncertainty around the coronavirus, and how long our communities may be impacted by the pandemic, but it seems certain that decisions about how we work, travel and gather together will continue to be influenced for weeks and months still to come. Today we have made the decision to combine in-person and Virtual conference.

 

If you cannot attend in-person or virtual due to the restriction and time zone difference, you can access on-demand videos to this entire event, including synced audio/video and slides.

All posters will be in PDF format. You can visit them, upload and interact directly with the poster presenter. You can also exchange with speakers via direct or private exchange during the conference.

We will keep you informed of any new decision.

The present progress in the clinical application of FMT

Targeting Microbiota 2020 Peter Konturek v2Prof. Peter Konturek, the President of the International Society Microbiota (ISM) from the Teaching Hospital of the University of Jena, Germany will give opening introduction during the Targeting Microbiota 2020 Congress with a talk entitled "The present progress in the clinical application of FMT".

The 8th International World Congress on Targeting Microbiota 2020 Congress will be held in Paris this year on October 22-23, 2020.

Prof. Konturek highlighted:

During both days, many oral and poster communications will be presented and will cover many hot topics:

  • Microbiota 2020: Recent Advances & Perspectives
  • Challenges of microbiota sequencing and analyzing: How to manage the Big Data of sequencing?
  • Challenges of microbiota-host cross-talk understanding and intestinal microbiome signaling to extraintestinal organs
  • Food-microbiota interactions
  • Microbiota & medicine of tomorrow: Development of effective therapeutic strategies to manipulate the gut microbiota
  • Safety aspects of microbiota based therapies

During Targeting Microbiota 2020, we will try to answer many questions, among them:

  • Can we modulate the quality and diversity of human microbiota?
  • How to induce durable beneficial changes in gut microbiota?
  • Where is the red line of the gut microbiota manipulation?
  • What are the strategic mediators of gut microbiota?
  • How to understand better the role of bacterial metabolites?
  • What is the perfect microbiota "signature" and how to use it as a biomarker to "predict" and/or treat many diseases?
  • What is the influence of gut microbiota on the development and progression of chronic diseases?

I do believe that this would be the best future strategy for the 8th World Congress of Targeting Microbiota in 2020: a strong communication between basic, pre-clinical scientists and clinicians.

For more info, please follow this link to read the welcome note.

Microbiota in the Press & Media

  • 1
  • 2
  • 3
Prev Next